Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Aging Interruption,” Global Expansion Will Grow Nu Skin In 2007 – Chang

This article was originally published in The Rose Sheet

Executive Summary

Nu Skin will strengthen brand equity in the New Year with new technology, expansion in Asia and a renewed commitment to direct selling, the company said during a Nov. 30 investors conference in New York City

You may also be interested in...



Nanotechnology Benefits/Risks Presented To FDA Nanotech Task Force

Governments, businesses and academia should take a balanced approach in developing a policy framework for nanotechnology to reap its economic and societal benefits, according to Matthew Jaffe of the Washington, D.C. law firm Crowell & Moring

Nu Skin Gets Green Light To Commence Direct Sales In China

Nu Skin Enterprises will initiate direct sales activity in Shanghai in the fourth quarter after receiving an official notification of approval from the Chinese Ministry of Commerce, the company reported July 31

Nu Skin Refreshes Anti-Aging System With PHA Ingredients

Nu Skin is relaunching Nu Skin 180° Anti-Aging Skin Therapy System with formulas containing polyhydroxy acids to offer a less aggressive regimen positioned for all skin types, the direct seller said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel